Description
In this video, our speakers offer insights from both healthcare providers and patient advocates, highlighting key strategies to improve collaboration between patients and providers. They focus on enhancing understanding of rare liver diseases and promoting greater concordance with prescribed treatment plans, emphasizing the importance of patient engagement, clear communication, and shared decision-making to achieve better health outcomes.
This EASL Policy Dialogue episode is supported by Novo Nordisk and Grifols. EASL has received no input from Novo Nordisk and Grifols with regards to the content of this programme.